On the recordJuly 22, 2013
The reality is that these deals between brand-name and generic pharmaceutical companies delay the entry of generic medicines into the marketplace.
Source
congress.govEditor's note · Context
Grassley highlights how pay-for-delay deals postpone generic drug availability.
Share & report
More from Chuck Grassley
May 5, 2025
Mr. President, recently, medical student Match Day took place all across America. On Match Day, thousands of medical students learn where they will train for the next few years. In Iowa, our State continues to lead in producing top medical…
Jul 21, 2025
This document shows an extreme lack of effort and due diligence in the FBI’s investigation of former Secretary Clinton’s email usage and mishandling of highly classified information.
Jul 17, 2025
Mr. Bove has a strong legal background and has served his country honorably. He deserves fair treatment.
Other voices in this conversation
